President’s Vicious, Inhumane and Anti-Science Budget Threatens Our Progress Toward Eliminating HIV and Hepatitis C

On May 23, 2017, the President released his fiscal year 2018 budget, proposing dramatic and devastating cuts to non-defense discretionary programs, in addition to massive tax cuts for the wealthiest Americans. This budget sends a clear and vicious message about who and what the Administration values….Read More

Working at the State Level: Project Inform’s California Advocacy for 2017

State-level advocacy efforts are crucial to create lasting change. Often efforts that are started at local and state levels inform national trends and structural changes at the federal level (think about the history of same-sex marriage, health care reform, and syringe exchange in the United States)….Read More

To End AIDS in the United States, Stay True to the National HIV/AIDS Strategy

By Judith Auerbach, Robert Bank, Chris Collins, JD Davids, Rebecca Haag, David Ernesto Munar, Dana van Gorder, Phill Wilson and A. Toni Young Ten years ago, hundreds of organizations and individuals signed a petition calling on all presidential candidates to create a national AIDS strategy. We…Read More

CROI 2017: The best HIV cure will be built with us, not just for us

Among the world’s top scientific conferences on HIV, the Conference on Retroviruses and Opportunistic Infections (CROI) stands among the most prestigious. Only a handful of the top submissions of new scientific data are deemed worthy of stage time. Submissions deemed less worthy are relegated to the…Read More

CROI 2017: What’s Up with PrEP and STIs?

Critics have been warning since the concept of oral PrEP was in its infancy that it would lead to major increases in condomless sex among users and a corresponding dramatic spike in sexually transmitted infections (STIs). So far, the data have been inconclusive. A journal article…Read More

CROI 2017: Dapivirine ring for PrEP does not lower effectiveness of hormonal contraception

In previous study, certain HIV medications were found to lower the effectiveness of some hormonal contraceptives, including the NNRTI efavirenz (Sustiva). This presented concerns about the experimental NNRTI dapivirine that was already being used as a vaginal ring for PrEP in clinical study. A presentation at…Read More

CROI 2017: Two-drug maintenance regimen controls HIV as well as standard treatment

In a late-breaker presentation at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, data from the SWORD 1 & 2 studies showed that a two-drug regimen of dolutegravir (Tivicay, DTG) + rilpivirine (Edurant, RPV) suppressed HIV as well as various regimens of three…Read More